3-Amino-3-phenylpropionic acid
-
3-Amino-3-phenylpropionic acid
structure -
-
CAS No:
614-19-7
-
Formula:
C9H11NO2
-
Chemical Name:
3-Amino-3-phenylpropionic acid
-
Synonyms:
2-Amino-2-phenylpropansαure;Benzenepropanoicacid,βamino-;Benzenepropanoicacid,β-amino-,(±)-;DL-3-Amino-3-phenylpropionsαure;3-(PHENYLAMINO)PROPANOIC ACID;3-PHENYLAMINO-PROPIONIC ACID;beta-phenyl-beta-alanine;DL-beta-Homophenylglycine
- Categories:
-
CAS No:
Description
white crystalline powder
3-amino-3-phenylpropanoic acid is a beta-amino acid that is beta-alanine substituted at position 3 by a phenyl group. It is a tautomer of a 3-ammonio-3-phenylpropanoate.
3-Amino-3-phenylpropionic acid Basic Attributes
165.19
165.19
2803286
210-371-2
132827|32026|1979
DTXSID40449994
White to Almost white
29163990
Characteristics
63.3
-1.4
White aciform powder
1.1603 (rough estimate)
222 °C (dec.)(lit.)
293.03°C (rough estimate)
139.8±24.6 °C
1.5200 (estimate)
SOLUBLE
3.45±0.12(Predicted)
Keep in dark place,Inert atmosphere,Room temperature
Safety Information
NONH for all modes of transport
3
36/37/38
24/25-37/39
P210, P235+P410, P240, P241, P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P370+P378, P403+P233, P405, P407, P413, P420, P501
36/37/38
|Warning|H228 (100%): Flammable solid [Danger Flammable solids]|P210, P240, P241, P280, and P370+P378|Aggregated GHS information provided by 33 companies from 1 notifications to the ECHA C&L Inventory.|H228 (50%): Flammable solid [Danger Flammable solids]|P210, P235+P410, P240, P241, P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P370+P378, P403+P233, P405, P407, P413, P420, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
3-Amino-3-phenylpropionic acid Use and Manufacturing
In addition to the foregoing, numerous other chromatographic separations using a column bonded with a CSP including a derivatized cyclofructan residue were carried out. Tables 5-9 list some additional examples of chromatographic separations using a column bonded with a CSP of the present invention. AU examples of chromatographic separations using columns bonded with CSPs of the present invention were carried out using the following experimental conditions and procedures.|0132| The high performance liquid chromatography (HPLC) column packing system was composed of an air driven fluid pump (HASKEL, DSTV- 122), an air compressor, a pressure regulator, a low pressure gauge, two high-pressure gauges (10, 000 and 6, 000 psi), a slurry chamber, check valves, and tubings. The CSPs were slurry packed into a 25 cm x 0.46 cm (inner diameter, I. D.) stainless steel column.|0133| The HPLC system was an Agilent 1 100 system (Agilent Technologies, Palo Alto, CA), which consisted of a diode array detector, an autosampler, a binary pump, a temperature- controlled column chamber, and Chemstation software. All chiral analytes were dissolved in ethanol, methanol, or other appropriate mobile phases, as indicated. For the LC analysis, the injection volume and flow rate were 5 muL and 1 mL/min, respectively. Separations were carried out at room temperature (~20 0C) if not specified otherwise. The wavelengths of UV detection were 195, 200, 210, and 254 nm. The mobile phase was degassed by ultrasonication under vacuum for 5 min. Each sample was analyzed in duplicate. Three operation modes (the normal phase mode, polar organic mode, and reversed phase mode) were tested, unless indicated otherwise. In the normal phase mode, heptane with ethanol or isopropanol was used as the mobile phase. In some cases, trifluoroacetic acid (TFA) was used as an additive, as indicated. The mobile phase of the polar organic mode was composed of acetonitrile/methanol and small amounts of acetic acid and triethylamine. Water/acetonitrile or acetonitrile/acetate buffer (20 mM, pH = 4.1 ) was used as the mobile phase in the reversed-phase mode.|0134| Two different supercritical fluid chromatographic instruments were used. One was a Berger SFC unit with an FCM 1200 flow control module, a TCM 2100 thermal column module, a dual pump control module, and a column selection valve. The flow rate was 4 mL/min. The cosolvent was composed of methanol/ethanol/isopropanol = 1 : 1 : 1 and 0.2percent diethylamine (DEA). The gradient mobile phase composition was 5percent cosolvent hold during 0- 0.6 min, 5-60percent during 0.6-4.3 min, 60percent hold during 4.3-6.3 min, 60percent-5percent during 6.3-6.9 min, and 5percent hold during 6.9-8.0 min. The other SFC system was a Jasco (MD, USA) system comprised of an autosampler unit (AS-2059-SF Plus), a dual pump module (PU-2086 Plus), a column thermostat module (CO-2060 Plus), a UV/Vis detector (UV-2075 Plus), and a back pressure regulator module (SCH-Vch-BP). Unless otherwise specified, the mobile phase was composed of CCVmethanol (0.1 percent TFA or 0.1percent diethylamine). The flow rate was 3 mL/min.|0135| For the calculations of chromatographic data, the 'dead time' to was determined by the peak of the refractive index change due to the sample solvent or determined by injecting l , 3, 5-tri-/e/-/-butylbenzene in the normal phase mode.The reactions using E.coli were performed as follows. E. coli JM109/ptrp4_3BR and E. coli JM109/pSFN_BS cells were cultured in TB medium with ampicillin (100 mug/mL) at 37 °C for 16 h. For reactions with whole cells, after washing the cells with 5 mL of each culture, the mixtures (final volume 2.5 mL) contained 242 mM N-acetyl-(R, S)-beta-Phe and 100 mM Tris'HCl (pH 7.6). The mixtures were incubated at 37 °C for 24 h. The consumption of substrates and the production of beta-Phe were analyzed by HPLC. The final products were analyzed by chiral analysis using HPLC. Using JM109/ptrp4_3BR, 242 mM N-acetyl-racemic-beta-Phe was converted to (R)-beta-Phe with a 25percent yield (58 mM) and 99percent ee (enantiomer excess) for 24 h. Using JM109/pSFN_BS, N-acetyl-racemic-beta-Phe was converted to (S)-beta-Phe with a 45percent yield (108 mM) and 99percent ee for 24 h.
Used for biochemical research.
DL-β-Phenylalanine is a useful synthetic intermediate. It was used in the synthesis of platelet aggregation inhibitors. It was also used as a reagent to synthesize human gonadotropin-releasing hormone receptor antagonists
Computed Properties
Molecular Weight:165.19
XLogP3:-1.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:165.078978594
Monoisotopic Mass:165.078978594
Topological Polar Surface Area:63.3
Heavy Atom Count:12
Complexity:153
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 3-Amino-3-phenylpropionic acid
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of fine chemicals,pharmaceutical materials -
InquiryCAS No.: 614-19-7Grade: Pharmaceutical GradeContent: 99%
-
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 614-19-7Grade: Industrial GradeContent: 99%
Learn More Other Chemicals
-
3,5-DIBROMO-2-[[[(3,5-DINITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
535965-38-9
-
3,5-DIBROMO-2-[[[[(2-CHLOROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532386-89-3
-
3,5-DIBROMO-2-[[[(4-METHYL-3-NITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532943-48-9
-
3,5-DIBROMO-2-[[[[3-(2-FURANYL)-1-OXO-2-PROPENYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
586392-09-8
-
3,5-DIBROMO-2-[[[[(2-METHYLPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
531548-30-8
-
2-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid Formula
333340-54-8
-
3,5-DIBROMO-2-[[[[3-(PHENOXYMETHYL)BENZOYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
586393-79-5
-
3,5-DIBROMO-2-[[[(4-CHLOROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
531530-32-2
-
What is 2-Cyclopentyl-3-(2,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-oxo-4-isoquinolinecarboxylic acid
400073-92-9
-
What is 9-Octadecenoic acid (9Z)-, compd. with N,N-dimethylcyclohexanamine (1:1)
65122-23-8